Insider · CIK 0001632295
Elisabeth Sandoval Little
Files at YARW (VYNE Therapeutics Inc.), PRCT (PROCEPT BioRobotics Corp). First filing -, latest -.
Elisabeth Sandoval Little files SEC Form 4 as director at YARW (VYNE Therapeutics Inc.), and also at PRCT (PROCEPT BioRobotics Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Elisabeth Sandoval Little has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | YARW VYNE Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Dec 15, 2025 |
| Jun 10, 2025 | PRCT PROCEPT BioRobotics Corp | AGrant or award Common Stock | +1,538 | $0.00 | $0 | 12,561 | Jun 12, 2025 |
| Jun 10, 2025 | PRCT PROCEPT BioRobotics Corp | AGrant or award Stock Option (Right to Buy)derivative | +2,771 | $0.00 | $0 | 2,771 | Jun 12, 2025 |
| Dec 12, 2024 | YARW VYNE Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Dec 13, 2024 |
Questions about Elisabeth Sandoval Little
Answered from the filings on this page, as of the latest one.
Is Elisabeth Sandoval Little buying or selling?
Elisabeth Sandoval Little has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Elisabeth Sandoval Little's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elisabeth Sandoval Little has 0.
Where does Elisabeth Sandoval Little file Form 4?
Elisabeth Sandoval Little has filed Form 4 at YARW (VYNE Therapeutics Inc.); PRCT (PROCEPT BioRobotics Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.